Arnon Goldberg Selected Research

Venoms

1/2013	Immunotherapy with commercial venoms is efficacious for anaphylactic reactions to Vespa orientalis stings.
10/2007	Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals.
8/2007	Variability of venom skin tests.
1/2006	Reproducibility of skin testing and serum venom specific IgE in Hymenoptera venom allergy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arnon Goldberg Research Topics

Disease

17	Hypersensitivity (Allergy) 05/2017 - 04/2002
3	Anaphylaxis (Anaphylactic Shock) 01/2013 - 01/2006
3	Urticaria (Hives) 01/2006 - 07/2003
2	Asthma (Bronchial Asthma) 01/2017 - 07/2013
2	Drug Hypersensitivity (Drug Allergy) 01/2016 - 07/2003
2	Immediate Hypersensitivity 01/2016 - 01/2014
2	Neoplasms (Cancer) 01/2014 - 08/2005
2	Angioedema 01/2014 - 01/2006
2	Bites and Stings (Sting) 01/2013 - 10/2007
2	Venom Hypersensitivity 09/2009 - 08/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 07/2013
1	Hypothyroidism 05/2012
1	Hyperthyroidism 05/2012
1	Otitis Media with Effusion 02/2006
1	Insect Bites and Stings (Insect Bite) 01/2006
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2005
1	Exanthema (Rash) 08/2005
1	Chronic Urticaria 07/2004
1	Pruritus (Itching) 07/2003
1	Aspirin-Induced Asthma 07/2003
1	Nasal Obstruction 03/2003

Drug/Important Bio-Agent (IBA)

4	VenomsIBA 01/2013 - 01/2006
3	Arthropod VenomsIBA 05/2017 - 01/2006
2	Penicillins (Penicillin)FDA Link 05/2017 - 01/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 01/2014
2	Carboplatin (JM8)FDA LinkGeneric 01/2014 - 08/2005
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 07/2003
2	Immunoglobulin E (IgE)IBA 02/2006 - 01/2006
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2017
1	Tryptases (Tryptase)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	penicilloyl polylysineIBA 01/2016
1	LactamsIBA 01/2016
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2016
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2016
1	RyanodineIBA 07/2013
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 07/2013
1	Phospholipases (Phospholipase)IBA 01/2013
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2013
1	AntigensIBA 01/2013
1	AntibodiesIBA 05/2012
1	Bee Venoms (Bee Venom)IBA 01/2011
1	Wasp Venoms (Venom, Wasp)IBA 01/2011
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2006
1	Mast Cell StabilizersIBA 02/2006
1	Ketotifen (Ketotifene)FDA Link 02/2006
1	Proton Pump InhibitorsIBA 01/2006
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2006
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2005
1	IodineIBA 08/2004
1	CytokinesIBA 07/2004
1	Interleukin-4 (Interleukin 4)IBA 07/2004
1	Nabumetone FDA LinkGeneric 07/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2003
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2002

Therapy/Procedure

4	Immunotherapy 01/2013 - 10/2007
2	Injections 01/2010 - 10/2007
1	Drug Therapy (Chemotherapy) 01/2014
1	Controlled Hypotension 01/2006
1	Therapeutics 08/2005
1	Nasal Surgical Procedures 03/2003